You are here: All Products  > Shanghai Zerun, a Novel Vaccine Company, Raises $29 Million to Reduce Debt

Shanghai Zerun, a Novel Vaccine Company, Raises $29 Million to Reduce Debt

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products